The Reversal Initiative Team
AI researchers and computational scientists on a personal mission to reverse Alzheimer's disease. Powered by top-tier peer-reviewed research.
David Scott Lewis
Nearly 5 decades of experience at the forefront of technology and innovation. AI researcher since the 1990s. Former EVP at META Group (now part of Gartner), with senior leadership roles at Microsoft, Samsung, and Oracle. Educational background and academic affiliations include Harvard, Stanford, and Caltech. Author of 54 peer-reviewed acceptances (public on OpenReview, mostly conference workshops) spanning AI, computational biology, and multi-agent systems, including 28+ bio-focused papers. Delivered an AAAI-26 Bridge Program oral presentation and serves as an IROS invited speaker. Founding member of the Caltech-MIT Enterprise Forum. Creator of the Validated Accelerated Pipeline (VAP) and Automated Computational Hypothesis Testing (ACHT) frameworks that form the backbone of our platform.
Enrique Zueco
Co-author of 54 peer-reviewed acceptances (public on OpenReview, mostly conference workshops) in computational biology, AI drug discovery, and multi-agent systems, including 28+ bio-focused papers. Deep expertise in multi-agent system architecture and the principal architect of the AI-Scientist v2 framework. Community Fund Board Member of Energy Web Foundation (alongside Deloitte, Shell, EF), bringing a decade of experience in scaling technology ventures from concept to production. Bridges the gap between cutting-edge research and practical deployment, ensuring our computational tools deliver real-world results.
